PAM
KYTH

Paradigm Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Paradigm Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,400
Closed -$308K – 853
2014
Q3 		$308K Sell
9,400
-1,600
-15% -$56.4K 0.04% 413
2014
Q2 		$422K Buy
11,000
+600
+6% +$20.9K 0.06% 349
2014
Q1 		$414K Sell
10,400
-800
-7% -$35.8K 0.06% 353
2013
Q4 		$417K Sell
11,200
-1,200
-10% -$49.8K 0.06% 349
2013
Q3 		$567K Buy
+12,400
New +$371K 0.09% 234

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Paradigm Asset Management's KYTH Position: Q4 2014 in Review

Paradigm Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 9,400 shares — an estimated $308K sold.

Paradigm Asset Management first reported a position in KYTH in Q3 2013 and held it in 5 quarters. The position peaked at $567K in Q3 2013. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

  • Paradigm Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
  • Paradigm Asset Management sold 9,400 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $308K.
  • Paradigm Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 5 quarters.
  • Paradigm Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $567K in Q3 2013.
  • 106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Paradigm Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.